[{"Assets_0_Q3_USD":140696347.0,"CommonStockSharesOutstanding_0_Q3_shares":94472389.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-56269138.0,"NetIncomeLoss_1_Q3_USD":-25015672.0,"NetIncomeLoss_3_Q3_USD":-64005625.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":92423122.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":91350117.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":92423122.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":91350117.0,"StockholdersEquity_0_Q3_USD":103612905.0,"EarningsPerShareBasic_1_Q3_USD":-0.27,"EarningsPerShareBasic_3_Q3_USD":-0.7,"EarningsPerShareDiluted_1_Q3_USD":-0.27,"EarningsPerShareDiluted_3_Q3_USD":-0.7,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":2000868.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":27979273.0,"Ticker":"INO","CIK":"1055726","name":"INOVIO PHARMACEUTICALS, INC.","OfficialName":"Inovio Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"674206680.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20181108"}]